(Q34921362)

5 August 2017

1 reference

title

Management of angiosarcoma (English)

1 reference

5 August 2017

G Thomas Budd

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

5 August 2017

published in

Current Oncology Reports

1 reference

5 August 2017

volume

4

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

515-519

1 reference

MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-002-0066-3

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice

21 January 2018

1 reference

12 December 2020

Suppression of rhabdomyosarcoma growth by fumagillin analog TNP-470

1 reference

12 December 2020

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

1 reference

12 December 2020

Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome

1 reference

12 December 2020

Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas

1 reference

12 December 2020

The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice

1 reference

12 December 2020

Angiosarcoma of the scalp and face: failure of an interferon alpha treatment

1 reference

12 December 2020

The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth

1 reference

12 December 2020

Angiogenesis in malignant fibrous histiocytoma

1 reference

12 December 2020

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types

1 reference

12 December 2020

Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome).

1 reference

12 December 2020

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

12 December 2020

Angiosarcomas in lymphedematous limbs.

1 reference

12 December 2020

Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience

1 reference

12 December 2020

Sarcoma arising in irradiated bone: report of eleven cases. 1948.

1 reference

12 December 2020

Patterns of expression and secretion of vascular endothelial growth factor in malignant soft-tissue tumours

1 reference

12 December 2020

Expression of basic fibroblast growth factor and its receptor in angiosarcoma

1 reference

12 December 2020

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

12 December 2020

Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica

1 reference

12 December 2020

Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma.

1 reference

12 December 2020

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

1 reference

12 December 2020

A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue sarcomas or bone sarcomas.

1 reference

12 December 2020

Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells.

1 reference

12 December 2020

Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas

1 reference

12 December 2020

Angiogenesis: regulators and clinical applications

1 reference

12 December 2020

Regression of metastatic angiosarcoma of the skin after systemic treatment with liposome-encapsulated doxorubicin and interferon-alpha

1 reference

12 December 2020

Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).

1 reference

12 December 2020

Surgical treatment of adult primary hepatic sarcoma

1 reference

12 December 2020

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

12 December 2020

Phase II trial of paclitaxel in patients with soft-tissue sarcoma

1 reference

12 December 2020

Different patterns of angiogenesis in sarcomas and carcinomas.

1 reference

12 December 2020

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A Southwest Oncology Group study

1 reference

12 December 2020

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

1 reference

12 December 2020

Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers

1 reference

12 December 2020

Sarcoma as a second malignancy after treatment for breast cancer.

1 reference

12 December 2020

Therapeutic efficacy of interferon alfa-2a and 13-cis-retinoic acid in recurrent angiosarcoma of the head

1 reference

12 December 2020

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue

1 reference

12 December 2020

Angiosarcoma of the face and scalp, prognosis and treatment

1 reference

12 December 2020

Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas.

1 reference

12 December 2020

A novel animal model for hemangiomas: inhibition of hemangioma development by the angiogenesis inhibitor TNP-470.

1 reference

12 December 2020

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

12 December 2020

Phase II Trials of Interferons-α and -β in Advanced Sarcomas

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma

1 reference

12 December 2020

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

12 December 2020

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

1 reference

12 December 2020

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

1 reference

12 December 2020

Classics in oncology: lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica.

1 reference

12 December 2020

10.1007/S11912-002-0066-3

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1039717850

0 references

1 reference